TIXOCORTOL EG 1%, nasal suspension bottle, 10 ml
Active ingredients: Tixocortol pivalate
Commercialized according to BDPMDispensing in France: Prescription only
Suspensionbottle, 10 mlnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TIXOCORTOL EG 1%, suspension nasale
- Pharmaceutical form
- suspension
- Route of administration
- nasale
- Presentation description
- 1 flacon(s) pulvérisateur(s) polyéthylène de 10 ml avec pompe(s) doseuse(s) avec embout(s) nasal(aux)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Sept 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67515694CIP73025447CIP133400930254479Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TIXOCORTOL (PIVALATE DE)suspension | 1,000 g · 100 g de suspension nasale | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.